Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.49 CHF | -1.22% |
|
-7.29% | +88.66% |
06-20 | Top Premarket Gainers | MT |
06-17 | Transcript : Molecular Partners AG Presents at TD Cowen 2nd Annual Radiopharmaceutical Innovation Summit, Jun-17-2024 10:40 AM |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+88.66% | 241M | |
+16.44% | 122B | |
+18.94% | 114B | |
+19.62% | 25.71B | |
-25.37% | 19.02B | |
-20.21% | 15.83B | |
-20.20% | 15.32B | |
-47.37% | 14.88B | |
+59.91% | 14.82B | |
+4.35% | 14.1B |
- Stock Market
- Equities
- MOLN Stock
- News Molecular Partners AG
- Credit Suisse Cuts Price Target on Molecular Partners to CHF6 From CHF8, Lowers Probability of Success for Ensovibep to 5%, Keeps Neutral Rating